Introduction {#j_jvetres-2017-0035_s_001}
============

Respiratory diseases have a major impact on poultry health, not only directly influencing growth and viability, but possibly also leading to secondary infections. Low pathogenic avian influenza viruses (LPAIVs) are particularly important due to their widespread circulation in domestic poultry ([@j_jvetres-2017-0035_ref_013]). Considerable information on the epidemiology of LPAIVs in chickens and wild birds has been reported over the last few years because of influenza surveillance schemes throughout the world ([@j_jvetres-2017-0035_ref_015], [@j_jvetres-2017-0035_ref_019]). LPAIV (H9N2) infections are emerging respiratory problems in poultry industry causing huge economic losses, especially in the presence of other co-infecting pathogens. H9 subtype of avian influenza virus (AIV) is one of the subtypes most frequently isolated from domestic chickens ([@j_jvetres-2017-0035_ref_017]).

Infections with H9N2 viruses in domestic poultry are usually associated with decreased feed and water consumption and egg production, and are presented as mild respiratory diseases with low mortality ([@j_jvetres-2017-0035_ref_015]). However, during the last decade, the outbreaks of LPAIV (H9N2) infections with severe clinical signs, high mortality (20%--65%) and reduced production (up to 75%) have been reported in commercial poultry farms ([@j_jvetres-2017-0035_ref_014]). Similarly, an outbreak of H9N2 influenza virus infection in chickens in Hong Kong (A/chicken/Hong Kong/739/94) was associated with coughing and respiratory distress in 75% of the birds, with 10% mortality. Antibiotic treatment reduced the mortality rate, suggesting that bacteria may play a role in exhibition of the clinical signs ([@j_jvetres-2017-0035_ref_009], [@j_jvetres-2017-0035_ref_012]). Specific information about the pathological alterations during the course of co-infection with LPAIV (H9N2) and *E. coli* in poultry is not available. Hence the decision to study the effect of LPAIV infection on broiler chickens simultaneously challenged with *E. coli*. H9N2 AIV used in this study was isolated from live poultry markets of Pakistan. This study has been conducted as an experimental infection that addresses the query whether *E. coli* challenges pathogenesis and immune responses in avian influenza virus infections. The successful reproduction of clinical disease with this experimental model allowed us to investigate the role of *E. coli* in the pathogenesis of LPAIV (H9N2) infection and *vice versa*.

Material and Methods {#j_jvetres-2017-0035_s_002}
====================

Experimental birds and management {#j_jvetres-2017-0035_s_002_s_001}
---------------------------------

The study was carried out on three-week-old broiler chicks (n=100), procured from local hatchery. The chicks were shown to be negative for AIV infection using haemagglutination inhibition test and virus isolation for H5 and H9 subtypes ([@j_jvetres-2017-0035_ref_004]). Standard management was provided with feed and water *ad libitum*. Different persons performed the feeding of the broiler chicken in order to prevent cross-contamination. All experimental groups were provided identical management protocol. The birds were given standard antibacterial free feed having an anti-coccidial agent (salinomycin).

Preparation of inoculum {#j_jvetres-2017-0035_s_002_s_002}
-----------------------

*E. coli* strain (avian pathogenic strain) was kindly provided by Dr Muhammad Usman (Poultry Research Institute, Rawalpindi, Pakistan), originally isolated from chicken. Stock cultures of *E. coli* strain were stored in 40% glycerol broth at −80°C. *E. coli* stock culture was prepared by inoculating MacConkey agar with a loopful of reference *E. coli* strain culture and incubating at 37°C for 24 h. To prepare *E. coli* cultures for infecting birds by aerosol, 250 mL of Dulbecco\'s Modified Eagle\'s medium (DMEM, with Hepes 25 mM as neutralising medium) was inoculated with colonies from MacConkey agar plate and incubated in an orbital shaker at 37°C for 22 to 24 h. The estimated colony count was confirmed by plating 0.1 mL of 10^5^ dilution of the final culture onto separate MacConkey agar plates ([@j_jvetres-2017-0035_ref_020]).

Avian influenza A virus used in this study, namely A/chicken/Pakistan/10RS3039-284-48/2010 (H9N2), was a reasserting field virus isolated from diseased chicken and kindly provided by Dr Abdul Ghafar (National Agricultural Research Centre, Islamabad, Pakistan). Viral stocks were prepared and titrated in 10-day-old chicken embryonated eggs; the median embryo infectious dose (EID~50~) was calculated according to already reported procedures. The viral stocks were diluted in medium containing antimicrobial agents (brain-heart infusion (BHI) broth containing 200 U/mL of penicillin, 200 μg/mL of streptomycin, 100 U/mL of polymyxin B sulfate, and 250 μg/mL of gentamicin) to yield a final titre of 10^6^ EID~50~/mL ([@j_jvetres-2017-0035_ref_004], [@j_jvetres-2017-0035_ref_018]).

Experimental design {#j_jvetres-2017-0035_s_002_s_003}
-------------------

The experimental birds were randomly allocated into four groups with 25 birds in each group. The experimental groups were identified as follows: negative control group, *E. coli*, LPAI, and *E. coli*+LPAI. All birds were confirmed serologically naive and influenza virus free by haemagglutination inhibition test. The birds in negative control group remained untreated while the birds in group *E. coli* and LPAI were inoculated with *E. coli* (10^6^ cfu/mL) and LPAIV H9N2 (10^6^ EID~50~/mL/bird) through intratracheal route (IT), respectively, whereas the birds in group *E. coli*+LPAI were co-infected with both pathogens on the same day at dosages of 10^3^ cfu and 10^3^ EID~50~ per bird, respectively.

Clinical examination {#j_jvetres-2017-0035_s_002_s_004}
--------------------

The birds were monitored for clinical signs twice a day up to 14 days post-infection (dpi). All birds were weighed at the start and end of experiment and observations were recorded in the form of general condition of birds, as well as clinical signs of disease and mortality rate. Attention was paid to any kind of pathology, but especially to disorders of the respiratory system (head swelling, nasal discharge, sneezing, tracheal rales, coughing, and difficult breathing). A scoring system was used to evaluate the severity of clinical signs. Each clinical sign was scored by the following scale: 0 -- no sign; 1 -- mild or slight; 2 -- moderate; 3 -- severe. The mean clinical score was based on the sum of clinical scores for each sign divided by the number of birds in each group at each observation time as previously described ([@j_jvetres-2017-0035_ref_005]).

Macroscopic and microscopic examinations {#j_jvetres-2017-0035_s_002_s_005}
----------------------------------------

Birds were euthanised using an intracephalic injection of\' pentobarbital sodium (Anpro Pharmaceutical, Arcadia, USA) at 4, 8, and 12 dpi. Necropsy was performed immediately after the birds were euthanised. The pathological lesions were examined, with special attention paid to respiratory organs. Lesions of the trachea, bronchi, lungs, and air sacs were scored for gross severity. Briefly, respiratory organs were scored altogether on scale of 0 to 3, where 0 -- no lesions, l -- mild or slight lesions, 2 -- moderate lesions, and 3 -- severe lesions. The totals of scores of one experimental group were used for statistical comparison of the harshness of the lesions between the experimental birds. Trachea, lung, and air sac samples were taken from each necropsied bird and fixed in 10% formalin. After fixation, tissues were processed in paraffin, sectioned at 3 µm, and stained with haematoxylin and eosin. Histological lesions were graded as: (−) no lesion, (+) light, (++) moderate, or (+++) marked lesions as described previously ([@j_jvetres-2017-0035_ref_006]). Histopathological analyses were carried out by two certified veterinary pathologists.

Statistical analysis {#j_jvetres-2017-0035_s_002_s_006}
--------------------

Data was expressed as means ±SEM (standard error of the mean) and analysed using GraphPad Prism 6 software (Graph Pad Software Inc., USA). The Shapiro-Wilk Normality Test was used to test normal distribution of the data. One-way analysis of variance (ANOVA) including Bonferroni correction was used for normally distributed data at different time points in different groups. Not normally distributed data were analysed with a Kruskal-Wallis one-way ANOVA. The body weights were also analysed by the Kruskal-Wallis test. The mean tracheal mucosa thickness was analysed using the Tukey-Kramer honest significant difference test. A chi-square test for equality of proportions was performed to measure the statistical significance of the mortality. Differences were assumed as statistically significant at P \< 0.05.

Results {#j_jvetres-2017-0035_s_003}
=======

There were no clinical signs, gross lesions, or mortality in the uninfected control chickens. Birds in the *E. coli* group showed clinical signs of mild to moderate intensity sickness, including depression (25 birds), anorexia (25), sneezing ([@j_jvetres-2017-0035_ref_006]), respiratory distress ([@j_jvetres-2017-0035_ref_008]), ocular/nasal discharge ([@j_jvetres-2017-0035_ref_006]), head swelling ([@j_jvetres-2017-0035_ref_008]), and loose droppings ([@j_jvetres-2017-0035_ref_007]). Moreover, clinical signs of mild severity, including anorexia ([@j_jvetres-2017-0035_ref_009]), depression ([@j_jvetres-2017-0035_ref_008]), sneezing ([@j_jvetres-2017-0035_ref_002]), and respiratory distress ([@j_jvetres-2017-0035_ref_004]), were noticed in birds of the LPAI group. On the other hand, clinical signs of severe respiratory disease such as sickness (25 birds), depression (25), anorexia (25), sneezing ([@j_jvetres-2017-0035_ref_012]), respiratory distress ([@j_jvetres-2017-0035_ref_018]), ocular/nasal discharge ([@j_jvetres-2017-0035_ref_011]), head swelling ([@j_jvetres-2017-0035_ref_019]), and loose droppings ([@j_jvetres-2017-0035_ref_012]) were more pronounced and seen more frequently in *E. coli*+LPAI group than in the case of mono-infection with LPAI or *E. coli* ([Table 1](#j_jvetres-2017-0035_tab_001){ref-type="table"}). Mean clinical scores of each group are presented in [Fig. 1.](#j_jvetres-2017-0035_fig_001){ref-type="fig"}

###### 

Number of infected chickens showing clinical disease signs

  Clinical signs                                                                   Negative control                                                    *E.* co/z-challenged                                                LPAI-challenged                                                     *E.* co/Z+LPAI-challenged
  -------------------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------
  General sickness                                                                 --                                                                  ++ (25)                                                             \+ (8)                                                              +++ (25)
  Depression                                                                       --                                                                  ++ (25)                                                             \+ (8)                                                              +++ (25)
  Anorexia                                                                         --                                                                  ++ (25)                                                             \+ (9)                                                              ++ (25)
  Sneezing                                                                         --                                                                  \+ (6)                                                              \+ (2)                                                              ++(12)
  Respiratory distress                                                             --                                                                  \+ (8)                                                              \+ (4)                                                              ++ (18)
  Ocular/nasal discharge                                                           --                                                                  \+ (6)                                                              --                                                                  ++ (11)
  Head swelling                                                                    --                                                                  \+ (8)                                                              --                                                                  ++ (19)
  Loose droppings                                                                  --                                                                  \+ (7)                                                              --                                                                  \+ (12)
  Mortality                                                                        --                                                                  \(4\)                                                               --                                                                  (10)[\*](#j_jvetres-2017-0035_fn_001){ref-type="table-fn"}
  Mean body weight [\*\*](#j_jvetres-2017-0035_fn_002){ref-type="table-fn"}± SEM   1.889 ± 19.5[a](#j_jvetres-2017-0035_fn_003){ref-type="table-fn"}   1.775 ± 55.4[b](#j_jvetres-2017-0035_fn_003){ref-type="table-fn"}   1.848 ± 13.7[a](#j_jvetres-2017-0035_fn_003){ref-type="table-fn"}   1.662 ± 17.6[c](#j_jvetres-2017-0035_fn_003){ref-type="table-fn"}

-- absence of apparent clinical disease signs, + mild, ++ moderate, and +++ severe signs

Mortality of five chickens at day 4 post virus challenge,

body weight was measured at the end of experiment (14 days post virus inoculation).

Mean values in the same row that do not share a common letter differ significantly (P \< 0.05)

![Clinical scores in different groups of broilers after inoculation with LPAIV or *E. coli* (O78) or a combination of both. Each clinical sign was scored by the following scale: 0 -- no sign, 1 -- mild or slight; 2 -- moderate, 3 -- severe](jvetres-61-253_g001){#j_jvetres-2017-0035_fig_001}

Gross and histopathological findings {#j_jvetres-2017-0035_s_003_s_001}
------------------------------------

No bird in the negative control group demonstrated body cavity lesions and all organs were normal in size, shape and consistency. In *E. coli* group, walls of thoracic air sacs were cloudy and thick. The amassing of serofibrinous exudates of varying amounts in thoracic /air sac, as well as fibrin accumulation in the liver and heart, and haemorrhages in the kidneys were also noticed in this group. On the other hand, only mild airsacculitis, tracheal congestion and nephritis were observed in birds of the LPAI group. In *E. coli*+LPAI group, large amounts of catarrhal exudates were grossly seen in the trachea. Mean gross lesions scores of respiratory organs are presented in [Fig. 2.](#j_jvetres-2017-0035_fig_002){ref-type="fig"} The tracheal mucosal membranes of these birds were erythematous and thick, having a layer of mucus over it ([Table 2](#j_jvetres-2017-0035_tab_002){ref-type="table"}). Both the thoracic air sacs and the abdominal air sacs were recurrently filled by serofibrinous exudate. Severe gross lesions in the liver and heart increased in size, haemorrhages, oedema, and fibrin accumulation were more prominent in this group. The gross lesions such as tracheal congestion, airsacculitis, pneumonia, and perihepatitis were most prominent on 4 dpi in all infected groups while less prominent on 8 and 12 dpi. The comparison of pathological lesion scores in the respiratory system is shown in [Table 3](#j_jvetres-2017-0035_tab_003){ref-type="table"}. Lesion scores in LPAI group did not show a statistically significant difference (P \< 0.005) compared to the non-challenged control broiler birds, apart from a mild congestion of tracheal mucosa and kidneys. The pathological score as well as total lesion score of birds in *E. coli* group were higher (P \< 0.005) than in the control birds. The pathological lesion score in chickens of *E. coli*+LPAI group had statistically significant increased values compared to *E. coli* group or control negative group (P \< 0.005).

###### 

Summary of post-challenge mortality and tracheal mucosal thickness analysis

                               Post challenge mortality   Tracheal mucosal thickness                                                                              
  ---------------------------- -------------------------- ---------------------------- -------------- ----------------------------------------------------------- --------------
                               birds                      birds                        significance   (µm)[A](#j_jvetres-2017-0035_fn_006){ref-type="table-fn"}   significance
  Control negative             0                          0                            C              71.25 ± 35.68                                               C
  *E. coli*-challenged         4                          16                           B              106.5 ± 21.29                                               B
  LPAI-challenged              0                          0                            C              78.17 ± 16.85                                               C
  *E. coli* +LPAI-challenged   10                         40                           A              163.12 ± 18.25                                              A

Mean of mucosal thickness of 10 tracheas, measured at four equidistant points. Values with different capital letters are significantly different at P \< 0.05

###### 

Summary of microscopic lesions and their intensity (+++ severe, ++ moderate, + mild, -- absent or normal)

                     Intensity of microscopic lesions                                            
  ------------------ ---------------------------------- ----- ----- ----- ----- ---- ----- ----- ----
  Control negative   --                                 --    --    --    --    --   --    --    --
  *E. coli*          --                                 --    \+    --    --    --   \+    ++    ++
  LPAI               ++                                 ++    ++    \+    \+    \+   ++    \+    \+
  *E. coli*+LPAI     +++                                +++   +++   +++   +++   ++   +++   +++   ++

![Macroscopic lesions score in the trachea, lungs, and airsacs of broiler chickens challenged with *E. coli* (O78) and LPAIV singly or in combination](jvetres-61-253_g002){#j_jvetres-2017-0035_fig_002}

In the control negative birds, all examined organs were histologically normal and there were no detectable lesions. The thickness of tracheal and primary bronchial respiratory epithelium in control group was 75.78 mm on an average. In LPAI group, the thickness of tracheal and primary bronchial respiratory epithelium did not show any statistical difference when compared to the control birds.

However, *E. coli* group had significantly thicker respiratory epithelium (P \< 0.05) as compared to control and LPAI group. Furthermore, the respiratory epithelium of the trachea and primary bronchi in *E. coli*+LPAI group was statistically significantly thicker than those of control birds (P \< 0.05), LPAI group (P \< 0.05), and *E. coli* group (P \< 0.05).

The respiratory epithelium of control birds was topped by ciliated columnar epithelium and mucus filled goblet cells. No lymphocyte and histiocyte infiltration was recorded. In the LPAI group, in some places the respiratory epithelium was discontinued and absence of cilia and desquamation were observed in the epithelial cells in these places. The histological lesion score was statistically higher (P \< 0.05) than that of the control group. In *E. coli* group, the epithelial cells of various parts of the trachea and primary bronchi did not have cilia, which were degenerated, and had fewer mucosal glands, located haphazardly in the oedematous and lymphocyte and histiocyte infiltrated respiratory epithelium. The histological score was statistically higher (P \< 0.05) as compared to LPAI group. The respiratory epithelium of co-infected birds showed epithelial cell degeneration. A large number of these cells showed the loss of cilia (thrown off in various places). Mucosal glands were reduced and were found infiltrated with lymphocytes and histiocytes. These lesions were found on the entire respiratory epithelium. Lesion score of this group was statistically higher (P \< 0.05) when compared to birds in LPAI and *E. coli* group.

Histological examination of the lung revealed non-ciliated epithelial flat cells in the secondary bronchi and parabronchi of control birds. No lymphocyte infiltration was observed in the inter-atrial and inter-parabronchial septa or around the blood vessels. Few small-sized germinal centres were seen. The lung of the birds in the group was similar to the control birds. The lungs of *E. coli* group had degeneration and hyperplasia of non-ciliated epithelial cell layer in the secondary bronchi and parabronchi. Furthermore, lymphocyte infiltration was observed in the inter-atrial and inter-parabronchial septa. Germinal centres were increased in size around secondary bronchi and blood vessels. In co-challenged birds, thick inter-atrial and inter-parabronchial septa were seen in the lungs. The infiltration of dispersed lymphocytes around the secondary bronchi and blood vessels was combined with germinal centres. All these lesions depict interstitial pneumonia. The assembling of cellular debris, serous exudates, and neutrophil infiltration in the atrium, infundibulum, para-bronchi, and secondary bronchi (catarrhal pneumonia) was observed less commonly in *E. coli* and *E. coli*+LPAI challenged group.

Seroconversion {#j_jvetres-2017-0035_s_003_s_002}
--------------

The sera of birds from control negative group and *E. coli* group were negative in the haemagglutination-inhibition test while those of the birds from group LPAI and group *E. coli*+LPAI were positive for the inoculated virus using HI test on the 4th, 8th, and 12th day of infection ([Table 4](#j_jvetres-2017-0035_tab_004){ref-type="table"}). The HI titre in birds of LPAI group was significantly lower (P \< 0.05) than HI titre of the group *E. coli*+LPAI. Jointly, the geometric mean titre (GMT) was higher (P *\<* 0.05) in birds of the group *E. coli*+LPAI than the group LPAI at 4, 8 and 12 days post virus infection. In our study, the geometric mean titres of LPAI and *E. coli*+LPAI groups were log2 4.8 on 4 dpi to log2 6.1 on 12 dpi, and log27.4 on 4 dpi to log2 8.4 on 12 dpi, respectively.

###### 

HI titres in sera from virus inoculated chickens in different groups

  Groups                      Pre-infection HI titre log~2~ HI titre   Number of chickens positive for HI/total chickens log~2~ HI titre range (GMT; mean ± SEM)                                                                           
  --------------------------- ---------------------------------------- ------------------------------------------------------------------------------------------- ----------------------------------------------------------------------- ---------------------------------------------------------------------
  LPAI-challenged             \<2                                      10/10 (4.8 ±0.3)[a](#j_jvetres-2017-0035_fn_007){ref-type="table-fn"}                       10/10 (5.2 ±0.7)[a](#j_jvetres-2017-0035_fn_007){ref-type="table-fn"}   6/6 (6.1 ±0.5)[a](#j_jvetres-2017-0035_fn_007){ref-type="table-fn"}
  *E. coli*+LPAI-challenged   \<2                                      10/10 (7.4 ±0.5)[b](#j_jvetres-2017-0035_fn_007){ref-type="table-fn"}                       10/10 (8.6 ±0.6)[b](#j_jvetres-2017-0035_fn_007){ref-type="table-fn"}   6/6 (8.4 ±0.3)[b](#j_jvetres-2017-0035_fn_007){ref-type="table-fn"}

GMT − geometric mean titre, dpi − days post virus infection. HI titres 8 or lower were considered negative for seroconversion.

Mean values in the same column that do not share a common letter differ significantly (P \< 0.05)

Discussion {#j_jvetres-2017-0035_s_004}
==========

It is a well-known fact that upper respiratory tract viral infections in poultry are often complicated by more serious bacterial diseases. Influenza virus is most commonly recognised in this context, and may also predispose to secondary infections. The co-infection with *E. coli* and influenza viruses in poultry has been observed under field conditions. Natural AIV/bacterial problems usually occur simultaneously and have been reported in poultry ([@j_jvetres-2017-0035_ref_009], [@j_jvetres-2017-0035_ref_010]), but the adverse effects of such co-infections on the health of broilers are not well-known. Co-infections of poultry present a complicated clinical picture confusing the identification and diagnosis, and unfortunately little is known about the interactions between co-infecting pathogens ([@j_jvetres-2017-0035_ref_003], [@j_jvetres-2017-0035_ref_009]).

In the present study, classical clinical signs of *E. coli* and LPAIV (H9N2) infection were observed in all infected groups, as described previously ([@j_jvetres-2017-0035_ref_004]). However, clinical signs were more severe and prominent in co-infected birds. Moreover, mortality was observed in *E. coli* (16%) and *E. coli*+LPAI group (40%). The clinical signs and gross lesions in LPAIV (H9N2) infected chicks were less severe than the lesions reported previously in chickens naturally infected with H9N2 ([@j_jvetres-2017-0035_ref_007]). In this study, no mortality occurred in the experimental group which was infected by H9N2 LPAIV. Nili and Asasi ([@j_jvetres-2017-0035_ref_008]) reported that experimental infection of broilers with AIV H9N2 caused severe necrotising tracheitis and 19% mortality, but it was not shown that the inocula were free from other pathogens. In this study, the inocula used for experimental challenge were negative for bacterial and fungal contamination, as well as Newcastle disease virus and *Mycoplasma gallisepticum*. Lesions in the airsacs of both *E. coli*+LPAI group were more pronounced and of longer duration than in the *E. coli* group. In the airsacs and lungs, the numbers of macrophages remained high in the *E. coli*+LPAI group, whereas the number of macrophages in the *E. coli* group decreased. Higher population of both T cells and macrophages might be responsible for the enhanced disease severity and lesions, possibly due to overproduction of inflammatory cytokines, as demonstrated in a study with turkeys ([@j_jvetres-2017-0035_ref_011]).

The present study revealed that pathogenicity of H9N2 virus is affected by the co-infection with *E. coli.* It is not known how *E. coli* bacteria enhance the replication of H9N2 virus in chickens. Post-translational proteolytic activation of the precursor of HA molecule into HA1 and HA2 subunits by host proteases is essential for infectivity and for the spread of the virus. Thus, virus activation by the host proteases plays a vital role in the spread of infection, tissue tropism, and pathogenicity of LPAIV ([@j_jvetres-2017-0035_ref_015]). *E. coli* co-infection may have provided the protease enzymes and enhanced H9N2 pathogenicity in this experiment. It was demonstrated that the protease of *S. aureus* activated the HA of the influenza virus, allowing multiple cycles of virus replication in the lungs of mice ([@j_jvetres-2017-0035_ref_016]). Co-infection with *E. coli* may confer a similar effect on H9N2 virus infection in chickens. An alternative explanation for the exacerbation of the pathogenicity of H9N2 influenza virus infection is that the stress of bacterial infection affects the immune system of chickens. This result implies that the intratracheal AI challenge by itself is not enough to produce severe disease and mortality in broilers and that the *E. coli* challenge was required to induce the mortality supporting findings of Nili and Asasi ([@j_jvetres-2017-0035_ref_008]).

It is well known that *E. coli*, through various virulence factors such as hydrogen peroxide, nitrous oxide, and various proteases can cause significant necrosis of the host cells, excessive release of pro-inflammatory cytokines, inhibit phagocytosis, and affect the normal functions of B and T lymphocytes, which may increase replication of viruses. Therefore, it can be assumed that the presence of *E. coli* may predispose the host to several other viral and bacterial infections. Avian influenza HI titre in the group co-infected with LPAIV and *E. coli* was significantly higher than in the group infected with LPAIV alone on 4, 8, and 12 dpi (P \< 0.05). This finding may show that *E. coli* could enhance the propagation of the virus and consequently an increase in its HI titre. It has been demonstrated that stimulation of host cells to produce or secrete more protease and the destruction of endogenous cell protease inhibitors may increase trypsin-like protease activity and enhance influenza virus pathogenicity ([@j_jvetres-2017-0035_ref_001]). Our field observation indicates that flocks which are positive to H9N2 have shown increase in mortality in recent years probably due to increased pathogenicity of the virus or due to other undetected field infections. It was speculated that severe clinical signs linked to H9N2 infections in the field were due to stress and co-infections, most likely due to *E. coli* involvement ([@j_jvetres-2017-0035_ref_002]). Moreover, a significant increase in the thickness of the trachea indicates that these pathogens have strong affinity for tracheal mucosa leading to loss of cilia, oedema, degeneration, and metaplasia of epithelial cells in *E. coli*+LPAI group.

In summary, we have verified that co-infection of broilers with *E. coli* and LPAI H9N2 may result in adverse respiratory diseases leading to significant economic losses because of poor weight gain, dropped egg production, and higher mortality rate. New strategies are needed to fight against such co-infections. Continuous surveillance of AI infection and co-infections studies in experimental poultry models is warranted to find new strategies to control their circulation in domestic and wild poultry. The timing of co-infection would also require further systematic experimental studies to understand the role of prior/post/simultaneous inoculation in disease outcome, pathogenesis, and virus shedding pattern.
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